Keyphrases
Immune Checkpoint Blockade
100%
Potentiation
100%
Lysis
100%
Newcastle Disease Virus
100%
Oncolytic Virus
100%
Programmed Death-ligand 1 (PD-L1)
50%
Antitumor Therapy
25%
Virus
12%
Clinical Trials
12%
Immune Response
12%
Tumor
12%
Syngeneic
12%
Overall Survival
12%
Tumor Cells
12%
Bladder Cancer
12%
Immune Infiltration
12%
Response Rate
12%
Tumor Control
12%
Cell Sensitivity
12%
Suboptimal Response
12%
Immunosuppressive Agents
12%
T-cell Phenotype
12%
Effector T Cells
12%
Targeting Antibodies
12%
Bladder Cancer Cells
12%
CTLA-4 Blockade
12%
Virus Therapy
12%
Innate Immune Pathways
12%
Immunogenic Potential
12%
Bladder Cancer Model
12%
Immunogenic Cell Death
12%
Immunology and Microbiology
Immune Checkpoint Blockade
100%
Newcastle Disease Virus
100%
Oncolytic Virus
100%
Cell Line
25%
Programmed Death-Ligand 1
25%
Virotherapy
12%
Syngenic
12%
Immunotherapy
12%
T Cell
12%
Tumor Cell
12%
Cancer Cell
12%
Upregulation
12%
Immune Response
12%
Immune Cell Infiltration
12%
Cell Death
12%
Overall Survival
12%
CTLA-4
12%
Flank
12%
Virus
12%
Infection
12%